Amom Mendes Nascimento

Amom Mendes Nascimento

Auto-generated profile, based on publicly available information

Amom Mendes Nascimento

Laboratório de Citogenômica, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
ÉZÉvelin A. Zanardo
Évelin A. Zanardo
FMFabíola P. Monteiro
Fabíola P. Monteiro
SCSamar Nasser Chehimi
Samar Nasser Chehimi
YOYanca G. Oliveira
Yanca G. Oliveira
ADAlexandre T. Dias
Alexandre T. Dias
LKLeslie Kulikowski
Leslie Kulikowski

30 September 2019 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SCSamar Nasser Chehimi
Samar Nasser Chehimi
ÉZÉvelin A. Zanardo
Évelin A. Zanardo
JCJosé R. M. Ceroni
José R. M. Ceroni
ANAmom M. Nascimento
Amom M. Nascimento
FMFabrícia A. R. Madia
Fabrícia A. R. Madia
LKLeslie Kulikowski
Leslie Kulikowski
Background: Cri du chat syndrome (CdCS) is a rare syndrome caused by a partial or complete deletion of the short arm of chromosome 5 (5p‐). The main clinical features include a high‐pitched cry, facial asymmetry, microcephaly, round face at birth, epicanthal folds, hypotonia, delayed growth and development.Methods: We studied 14 Brazilian patients with CdCS using genomic array in order to better define the 5p breakpoints and recognize copy number variations (CNVs) that contribute to clinical manifestations associated with the syndrome.Results: Array confirmed terminal deletions in 13 patients and an interstitial deletion in one patient. It was also possible to map the breakpoints and associate a genomic region of 4.7 Mb to the development of head circumference and cat‐like cry. We also found other CNVs concomitant to the 5p deletion including a 9p duplication, a 17q deletion, and a 22q deletion in three different patients.Conclusion: With advancements of molecular cytogenomic methods in the last two decades, it was possible to evidence cryptic alterations and improve the genotype–phenotype correlation. In this work, we describe a new genomic region associated with microcephaly and cat‐like cry and highlight the importance of precise delineation of 5p deletion breakpoints and detection of other CNVs in CdCS patients to improve genotype–phenotype correlation to perform a complete clinical and molecular diagnosis.

28 May 2022 in Clinics
Verified
Journal Article
Open access
SCSamar Nasser Chehimi
Samar Nasser Chehimi
VAVanessa Tavares Almeida
Vanessa Tavares Almeida
ANAmom Mendes Nascimento
Amom Mendes Nascimento
ÉZÉvelin Aline Zanardo
Évelin Aline Zanardo
YOYanca Gasparini de Oliveira
Yanca Gasparini de Oliveira
LKLeslie Kulikowski
Leslie Kulikowski
Copy Number Variations (CNVs) in the human genome account for common populational variations but can also be responsible for genetic syndromes depending on the affected region. Although a deletion in 5p is responsible for a syndrome with highly recognizable phenotypical features, other chromosomal abnormalities might overlap phenotypes, especially considering that most studies in 5p use traditional cytogenetic techniques and not molecular techniques. The authors have investigated 29 patients with clinical suspicion of 5p- syndrome using Chromosomal Microarray (CMA), and have gathered information on previous tests, clinical signs, symptoms, and development of the patients. The results showed 23 pure terminal deletions, one interstitial deletion, one deletion followed by a 3 Mb duplication in 5p, three cases of 5p deletion concomitant to duplications larger than 20 Mb in chromosomes 2, 9, and 18, and one 5p deletion with a chromosome Y deletion. CMA showed relevant CNVs not typically associated with 5p- that may have contributed to the final phenotype in these patients. The authors have identified three novel rearrangements between chromosomes 5 and 2 (Patient 27), 5 and 18 (Patient 11), and 5 and Y (Patient 22), with breakpoints and overlapped phenotypes that were not previously described. The authors also highlight the need for further molecular investigation using CMA, in different chromosomes beyond chromosome 5 (since those cases did not show only the typical deletion expected for the 5p- syndrome) to explain discordant chromosomal features and overlapped phenotypes to unravel the cause of the syndrome in atypical cases.

5 March 2024 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
MAMárcia Regina Gimenes Adriano
Márcia Regina Gimenes Adriano
ABAdriana Bortolai
Adriana Bortolai
FMFabricia Andreia Rosa Madia
Fabricia Andreia Rosa Madia
GCGleyson Francisco da Silva Carvalho
Gleyson Francisco da Silva Carvalho
ANAmom Mendes Nascimento
Amom Mendes Nascimento
ADAlexandre Torchio Dias
Alexandre Torchio Dias
Objectives: Male infertility accounts for approximately 30% of cases of reproductive failure. The characterization of genetic variants using cytogenomic techniques is essential for the adequate clinical management of these patients. We aimed to conduct a cytogenetic investigation of numerical and structural rearrangements and a genomic study of Y chromosome microdeletions/microduplications in infertile men derived from a single centre with over 14 years of experience. Results: We evaluated 151 infertile men in a transversal study using peripheral blood karyotypes and 15 patients with normal karyotypes through genomic investigation by multiplex ligation-dependent probe amplification (MLPA) or polymerase chain reaction of sequence-tagged sites (PCR-STS) techniques. Out of the 151 patients evaluated by karyotype, 13 presented chromosomal abnormalities: two had numerical alterations, and 11 had structural chromosomal rearrangements. PCR-STS detected a BPY2 gene region and RBMY2DP pseudogene region microdeletion in one patient. MLPA analysis allowed the identification of one patient with CDY2B_1 and CDY2B_2 probe duplications (CDY2B and NLGN4Y genes) and one patient with BPY2_1, BPY2_2, and BPY2_4 probe duplications (PRY and RBMY1J genes).